Maximus (NYSE:MMS) Announces Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Maximus (NYSE:MMS) issued its earnings results on Thursday. The health services provider reported $1.62 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.01), Zacks reports. The firm had revenue of $1.32 billion during the quarter, compared to the consensus estimate of $1.34 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The firm’s revenue for the quarter was up .2% on a year-over-year basis. During the same period in the previous year, the company posted $1.46 EPS. Maximus updated its FY 2026 guidance to 7.950-8.250 EPS.

Maximus Price Performance

Maximus stock opened at $77.89 on Thursday. The company has a market capitalization of $4.39 billion, a price-to-earnings ratio of 14.35 and a beta of 0.57. The company has a current ratio of 2.27, a quick ratio of 2.27 and a debt-to-equity ratio of 0.91. Maximus has a 12 month low of $63.77 and a 12 month high of $92.50. The stock’s 50 day moving average is $86.11 and its 200-day moving average is $79.33.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 1st. Shareholders of record on Friday, November 14th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, November 14th. This represents a $1.20 annualized dividend and a yield of 1.5%. Maximus’s dividend payout ratio (DPR) is 22.10%.

Insider Buying and Selling

In other Maximus news, insider Michelle F. Link sold 1,610 shares of the company’s stock in a transaction on Wednesday, October 1st. The stock was sold at an average price of $90.86, for a total value of $146,284.60. Following the transaction, the insider directly owned 13,508 shares of the company’s stock, valued at $1,227,336.88. This represents a 10.65% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 1.60% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in MMS. Danske Bank A S acquired a new stake in shares of Maximus in the third quarter valued at approximately $55,000. Advisory Services Network LLC acquired a new stake in Maximus during the third quarter worth approximately $32,000. Armistice Capital LLC grew its position in Maximus by 57.2% during the third quarter. Armistice Capital LLC now owns 5,727 shares of the health services provider’s stock worth $523,000 after buying an additional 2,084 shares in the last quarter. Voloridge Investment Management LLC increased its stake in Maximus by 3.8% during the 3rd quarter. Voloridge Investment Management LLC now owns 136,807 shares of the health services provider’s stock worth $12,500,000 after acquiring an additional 5,058 shares during the period. Finally, Wexford Capital LP acquired a new stake in shares of Maximus during the 3rd quarter worth $114,000. Institutional investors and hedge funds own 97.21% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have weighed in on MMS. Zacks Research downgraded Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 27th. Weiss Ratings raised shares of Maximus from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, October 8th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $90.00.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.